Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Colorcon
Julphar
Citi
Cerilliant
Baxter
Fish and Richardson
QuintilesIMS

Generated: May 24, 2018

DrugPatentWatch Database Preview

VALGANCICLOVIR HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Valganciclovir Hydrochloride patents expire, and when can generic versions of Valganciclovir Hydrochloride launch?

Valganciclovir Hydrochloride is a drug marketed by Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Endo Pharms Inc, and Hetero Labs Ltd V. and is included in six NDAs.

The generic ingredient in VALGANCICLOVIR HYDROCHLORIDE is valganciclovir hydrochloride. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the valganciclovir hydrochloride profile page.
Drug patent expirations by year for VALGANCICLOVIR HYDROCHLORIDE
Pharmacology for VALGANCICLOVIR HYDROCHLORIDE
Synonyms for VALGANCICLOVIR HYDROCHLORIDE
(S)-Valganciclovir Hydrochloride
[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxy-propyl] (2S)-2-amino-3-methyl-butanoate hydrochloride
[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate hydrochloride
175865-59-5
2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl Ester L-Valine Hydrochloride
2-[(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-amino-3-methylbutanoate hydrochloride hydrate
865V595
AC-7501
AC1L3802
ACT02670
AK-59963
AKOS015963325
AKOS030241609
AN-8918
BC215809
BS-1015
C14H22N6O5.HCl
C14H23ClN6O5
CAS-175865-59-5
CCG-213225
CHEMBL1200454
CS-1755
CTK8F1149
D03256
DSSTox_CID_26784
DSSTox_GSID_46784
DSSTox_RID_81902
DTXSID9046784
EBD4420
FT-0631198
HY-A0032A
J-011142
KB-278124
KS-00000XN5
L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester, monohydrochloride
L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, hydrochloride (1:1)
L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, monohydrochloride hydrate
L-Valine, ester with 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, monohydrochloride
L-Valine,2[(amino-1,6-dihydro-6-oxo-9H-purin-9-y1)methoxy]-3-hydroxypropyl ester, monohydrochloride
LS-173676
MFCD08460118
MLS003876616
MolPort-005-938-316
MolPort-028-751-165
NCGC00168779-01
NSC-760349
NSC760349
Pharmakon1600-01503870
R-127
RG-127
RO 107-9070/194
Ro-10-79070/194
Ro-1079070/194
Ro107-9070/194
RS 079070-194
RS-079070-194
RS-79070
RS-79070-194
SC-15265
SCHEMBL23225
SMR002533167
TA-9070
Tox21_112640
Valcyt
Valcyte
Valcyte (TN)
Valganciclovir (hydrochloride)
Valganciclovir HCl
Valganciclovir hydrochloride (JAN/USAN)
Valganciclovir hydrochloride [USAN:USP]
Valixa
ZORWARFPXPVJLW-MTFPJWTKSA-N

US Patents and Regulatory Information for VALGANCICLOVIR HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride FOR SOLUTION;ORAL 205220-001 Jul 18, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride TABLET;ORAL 206876-001 Dec 12, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride TABLET;ORAL 204750-001 Mar 31, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride TABLET;ORAL 203511-001 Nov 4, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Chinese Patent Office
Cantor Fitzgerald
Farmers Insurance
Citi
Teva
Merck
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.